SCHEMBL3808654

SCHEMBL3808654

CCOC(=O)CCCn1c(=O)n(C2CCN(C(=O)O)[C@@H](CCCN(Cc3ccccc3)Cc3ccccc3)C2)c2ccccc21.O=C(O)N1CC[C@H](N(c2ccccc2)S(=O)(=O)c2ccccc2)CC1CCCN(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 2/20 0.41
▸ TACR1 P25103 1/20 0.41
▸ CACNA1G O43497 3/20 0.36
▸ CACNA1H O95180 3/20 0.36
▸ MAPK1 P28482 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ TNF P01375 1/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ TAS2R14 Q9NYV8 3/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ OPRL1 P41146 1/20 0.32
▸ C5AR1 P21730 1/20 0.31
▸ CCR5 P51681 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4804462 0.90 CACNA1G (0.43) OPRM1TACR1CACNA1GCACNA1HALDH1A1
SCHEMBL4804476 0.78 CACNA1G (0.43) OPRM1TACR1CACNA1GCACNA1HALDH1A1
SCHEMBL4804471 0.78 CACNA1G (0.43) OPRM1TACR1CACNA1GCACNA1HALDH1A1
SCHEMBL3806319 0.77 CHRM5 (0.36) MAPK1ALDH1A1KMT2ACYP3A4TAS2R14
SCHEMBL4675598 0.76 CYP3A4 (0.40) OPRM1CACNA1GCACNA1HCYP3A4CYP2D6
SCHEMBL3665336 0.75 CHRM5 (0.36) CACNA1GCACNA1HC5AR1
SCHEMBL3670916 0.75 CHRM2 (0.38) OPRM1CACNA1GCACNA1HALDH1A1LMNA
SCHEMBL3665332 0.74 POLB (0.35) OPRM1CACNA1GCACNA1HALDH1A1OPRL1
SCHEMBL4804451 0.74 CACNA1G (0.43) OPRM1TACR1CACNA1GCACNA1HALDH1A1
SCHEMBL4681959 0.73 OPRL1 (0.44) OPRM1CACNA1GCACNA1HCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP claimed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO claimed
Send feedback